Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Champions Oncolog
(NQ:
CSBR
)
4.220
+0.040 (+0.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Champions Oncolog
< Previous
1
2
Next >
Champions Oncology Reports Quarterly Revenue of $14.0 Million
July 18, 2024
Via
ACCESSWIRE
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
July 11, 2024
Via
ACCESSWIRE
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
June 04, 2024
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.0 Million
March 12, 2024
Via
ACCESSWIRE
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
March 07, 2024
Via
ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
March 06, 2024
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $13.1 Million
July 24, 2023
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $11.6 Million
December 12, 2023
Via
ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
December 04, 2023
Via
ACCESSWIRE
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
November 02, 2023
Via
ACCESSWIRE
Champions Oncology Announces the Addition of Brady Davis as President
October 17, 2023
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.6 Million
September 13, 2023
Via
ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
September 11, 2023
Via
ACCESSWIRE
Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
August 22, 2023
Via
ACCESSWIRE
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
August 01, 2023
Via
ACCESSWIRE
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
July 20, 2023
Via
ACCESSWIRE
Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development
April 17, 2023
Via
ACCESSWIRE
Champions Oncology Announces $5M Stock Repurchase Program
April 05, 2023
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.8 Million
March 15, 2023
Via
ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023
March 13, 2023
Via
ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
December 13, 2022
Via
ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
December 09, 2022
Via
ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
September 08, 2022
Via
ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022
September 06, 2022
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Record Annual Revenue of $49.1 Million
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
July 14, 2022
HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
May 31, 2022
HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million
March 15, 2022
HACKENSACK, NJ / ACCESSWIRE / March 15, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.